The Forsyth Institute will renovate 8,935 sf adjacent to its new Kendall Square facility in Boston to create the Center for Discovery at the Host-Biofilm Interface (CHBI). Supported by $3 million in federal stimulus funding, the interdisciplinary project will house oral health research programs in areas including microbiology, molecular genetics, microbial informatics, and immunology.
George Washington University will renovate 25,400 sf of existing space in Washington to create the Research Center for the Neglected Diseases of Poverty. Housing translational research facilities for the development of new vaccines, therapeutics, and diagnostics, the center will support the study of neglected tropical diseases (NTDs) and neglected infections of poverty (NIPs) such as hookworm, schistosomiasis, opisthorchiasis, and toxoplasmosis. The multidisciplinary project is supported by $15 million in federal stimulus funding.
Duke University will create a biomedical research facility in the Fitzpatrick Center for Interdisciplinary Engineering, Medicine and Applied Sciences in Durham, N.C. Supported by $4.2 million in federal stimulus funding, the project includes conversion of existing shell space to house a vivarium, research laboratories, and offices. Supporting translational research for the development of advanced therapeutics, the facility will provide 2,520 mouse cages, 480 rat cages, and 40 cages for other species.
Dublin City University will build the 3,000-sm Nano-Bioanalytical Research Facility adjacent to the National Institute for Cellular Biotechnology in Dublin. The facility will support research in translational nano-medicine and is supported by €23.8 million in government funding.
Medical University of South Carolina will renovate the second and third floors of its Basic Sciences Building in Charleston, S.C. Supported by $15 million in federal stimulus funding, the project will provide advanced laboratories for multidisciplinary research. A-13,700-sf area on the second floor will be renovated to provide labs for molecular therapy, biodefense, emerging infectious diseases, microbiology, and basic immunology. The third floor will provide 19,000 sf of pharmacology, drug discovery, and pharmacogenetics research space.
Concorde Gruppe GmbH is partnering with Healthcare of Today to build a €50 million stem cell research and treatment facility in Adunatii Copaceni, Romania. Completion is expected in mid-2012. The facility will utilize patient stem cells in medical treatments and will promote innovation in the development of advanced stem cell therapies.
The University of Florida's $90.5 million Biomedical Sciences Building in Gainesville was awarded LEED Gold sustainable design certification in July of 2010. The eight-story, 163,000-sf translational research facility houses the Health Science Center Colleges, the Biomedical Engineering Department of the College of Engineering, and Animal Care Services. The building opened in November of 2009 and was dedicated in May of 2010.
Wayne County will begin construction in July of 2010 on the $1.5 million Michigan Center for Regenerative Medicine in Plymouth. The 21,000-sf facility will house wet labs, offices, and manufacturing space to support stem cell research and development for the pharmaceutical and biotech industries. The center will be operated by Michigan Research Institute in Ann Arbor with Innovative BioTherapies as the anchor tenant. Completion is expected in late fall of 2010.
The University of Mississippi will construct a second research facility at the Thad Cochran Research Center in Oxford, Miss. Providing expanded research space for the university's National Center for Natural Products Research, the building will include FDA clinical research labs and a botanical specimen repository. The project is supported by $31.7 million in funding from three federal agencies. Completion is expected in summer of 2013.
The University of Florida is planning to build a $30 million facility to house the Clinical and Translational Science Institute. The 80,000-sf project will be built as an addition to the planned Institute on Aging research complex in Gainesville. Completion is expected by March of 2013.
The University of South Florida is planning to construct the $20 million Center for Advanced Medical Learning and Simulation (CAMLS) in Tampa. Construction will begin on the 60,000-sf facility by January of 2011. The building will include an advanced surgical training laboratory, a virtual hospital with simulators, and a 150-seat videoconferencing auditorium. Completion is expected in 2012.
Children's Hospital of Philadelphia dedicated the $504 million Colket Translational Research Building in June of 2010. Located on the South Campus, the 12-story facility provides four laboratory floors, administrative offices, a cafeteria, conference space, and a two-story lobby. Four below-grade floors house infrastructure, laboratory support, and a central utility plant.
CPL Biologicals completed construction in June of 2010 on its vaccine manufacturing plant in Dholka, India. The 25,000-sf facility will utilize virus-like particle (VLP) technology to produce commercial-scale quantities of influenza vaccines. The plant will be able to produce over 60 million doses annually at full capacity. Ground was broken on the project in fall of 2009. CPL Biologicals is a joint venture of Novavax and Cadila Pharmaceuticals of India.
The University of Nevada is building the 57,814-sf William N. Pennington Health Sciences Building in Reno. Slated for completion in fall of 2011, the three-story facility will housing nursing and medical programs. The $48 million facility is being built by Sundt Construction of Tucson. Ground was broken on the project in December of 2009.
The University of Minnesota is planning to construct the $200 million Cancer/Cardiovascular Research Facility in Minneapolis. Construction will begin on the project in August of 2011 with completion slated for June of 2013. Housing research laboratories with advanced instrumentation, the project is part of Phase 2 of the University’s master plan for the Biomedical Discovery District. The architects for Phase 2 are Zimmer Gunsul Frasca Architects of Seattle and Architectural Alliance of Minneapolis.
